Dmitrii D. Sekhniaidze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dmitrii D. Sekhniaidze has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy V. Erygin
Oncology Center No. 1, S.S. Yudin City Clinical Hospital
2 shared publications - I. M. Borovkov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - I. V. Eltsov
Blokhin National Cancer Research Center
2 shared publications - Malik V. Agasiev
Moscow City Oncology Hospital No. 62
2 shared publications - Pavel V. Kononets
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Vladislav E. Bugaev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications
Latest Publications
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Results of the ESOSTAT multiple-center prospective study: analysis of 90-day postoperative morbidity and mortality after radical surgery for esophageal and esophagogastric junction cancer
Objective. To evaluate 90-day morbidity and mortality rates after elective radical surgery for esophageal and esophagogastric junction cancer within the prospective multiple-center study ESOSTAT. Material and methods. The study included 230 patients from 18 oncology hospitals in the Russian Federation and the Republic of Belarus who underwent elective radical esophagectomy for primary esophageal cancer or esophagogastric junction cancer (Siewert I–II) between March 18 and September 18, 2024. Complications were uniformly recorded using the ESODATA system with severity graded according to the Clavien-Dindo classification. Univariate and multivariate logistic regression analyses were performed to identify risk factors of postoperative complications and mortality. Results. The 90-day mortality rate was 8.7%, in-hospital mortality — 4.8%. The overall complication rate was 41.3%, including surgical complications in 26.5% of patients and redo surgeries in 17.4% of cases. The most common complications were pulmonary (22.1%) and anastomotic leakage (11.3%). The mortality rate associated with anastomotic leakage was 19.2%. Multivariate analysis identified female sex (OR=0.732; 95% CI 0.548–0.978; p=0.035), ECOG status 2 (OR=10.142; 95% CI 1.575–65.366; p=0.015), surgery time (OR=1.003; 95% CI 1.001–1.005; p=0.006), and intraoperative blood loss (OR=1.001; 95% CI 1.000–1.002; p=0.027) as independent predictors of complications. Factors independently associated with 90-day mortality were Charlson comorbidity index >4 (OR=1.260; 95% CI 1.062–1.495; p=0.008), complicated course of esophageal cancer (OR=1.560; 95% CI 0.637–2.305; p=0.025), concomitant pulmonary diseases (OR=3.328; 95% CI 1.083–10.227; p=0.036), and any postoperative complication (OR=36.554; 95% CI 15.800–84.521; p<0.001). Conclusion. The ESOSTAT study is the first in Russia and Belarus to evaluate 90-day morbidity and mortality rates after esophagectomy. Our findings are comparable with international registries, support 90-day follow-up period and identify key prognostic factors. Risk factor analysis will allow patient stratification according to the likelihood of adverse outcomes, facilitate more rigorous patient selection, and ultimately improve safety of surgical treatment.
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Results of the ESOSTAT multiple-center prospective study: analysis of 90-day postoperative morbidity and mortality after radical surgery for esophageal and esophagogastric junction cancer
Objective. To evaluate 90-day morbidity and mortality rates after elective radical surgery for esophageal and esophagogastric junction cancer within the prospective multiple-center study ESOSTAT. Material and methods. The study included 230 patients from 18 oncology hospitals in the Russian Federation and the Republic of Belarus who underwent elective radical esophagectomy for primary esophageal cancer or esophagogastric junction cancer (Siewert I–II) between March 18 and September 18, 2024. Complications were uniformly recorded using the ESODATA system with severity graded according to the Clavien-Dindo classification. Univariate and multivariate logistic regression analyses were performed to identify risk factors of postoperative complications and mortality. Results. The 90-day mortality rate was 8.7%, in-hospital mortality — 4.8%. The overall complication rate was 41.3%, including surgical complications in 26.5% of patients and redo surgeries in 17.4% of cases. The most common complications were pulmonary (22.1%) and anastomotic leakage (11.3%). The mortality rate associated with anastomotic leakage was 19.2%. Multivariate analysis identified female sex (OR=0.732; 95% CI 0.548–0.978; p=0.035), ECOG status 2 (OR=10.142; 95% CI 1.575–65.366; p=0.015), surgery time (OR=1.003; 95% CI 1.001–1.005; p=0.006), and intraoperative blood loss (OR=1.001; 95% CI 1.000–1.002; p=0.027) as independent predictors of complications. Factors independently associated with 90-day mortality were Charlson comorbidity index >4 (OR=1.260; 95% CI 1.062–1.495; p=0.008), complicated course of esophageal cancer (OR=1.560; 95% CI 0.637–2.305; p=0.025), concomitant pulmonary diseases (OR=3.328; 95% CI 1.083–10.227; p=0.036), and any postoperative complication (OR=36.554; 95% CI 15.800–84.521; p<0.001). Conclusion. The ESOSTAT study is the first in Russia and Belarus to evaluate 90-day morbidity and mortality rates after esophagectomy. Our findings are comparable with international registries, support 90-day follow-up period and identify key prognostic factors. Risk factor analysis will allow patient stratification according to the likelihood of adverse outcomes, facilitate more rigorous patient selection, and ultimately improve safety of surgical treatment.
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Minimally invasive segmentectomies in primary and metastatic lung tumors: a 5-year single-center experience
Objective. To analyze early and delayed postoperative outcomes after segmentectomies for lung tumors and solitary pulmonary metastases. Material ans methods. A retrospective analysis included 100 patients who underwent anatomical lung resection for primary or metastatic tumors. The Fisher’s exact test was used for statistical analysis, and differences were significant at p4 days, 10%) and pneumonia (5%). Serious complications (Clavien-Dindo ≥IIIa) were detected in 7% of patients. Statistical analysis found no significant differences in complication rates between groups of primary and metastatic tumors (p=0.73). Median disease-free period for primary tumors was 12 months. The one-year and two-year disease-free survival rates for stage I were 92% and 93.7%, for stage II — 50% and 50%, for stage III — 80% and 100%, respectively. No local recurrences were detected throughout the follow-up period. Conclusion. Minimally invasive segmentectomy does not compromise early postoperative outcomes in primary and metastatic lung tumors, as well as demonstrates high effectiveness regarding disease-free survival in primary lung tumors.
- 14 September 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 9
Minimally invasive segmentectomies in primary and metastatic lung tumors: a 5-year single-center experience
Objective. To analyze early and delayed postoperative outcomes after segmentectomies for lung tumors and solitary pulmonary metastases. Material ans methods. A retrospective analysis included 100 patients who underwent anatomical lung resection for primary or metastatic tumors. The Fisher’s exact test was used for statistical analysis, and differences were significant at p4 days, 10%) and pneumonia (5%). Serious complications (Clavien-Dindo ≥IIIa) were detected in 7% of patients. Statistical analysis found no significant differences in complication rates between groups of primary and metastatic tumors (p=0.73). Median disease-free period for primary tumors was 12 months. The one-year and two-year disease-free survival rates for stage I were 92% and 93.7%, for stage II — 50% and 50%, for stage III — 80% and 100%, respectively. No local recurrences were detected throughout the follow-up period. Conclusion. Minimally invasive segmentectomy does not compromise early postoperative outcomes in primary and metastatic lung tumors, as well as demonstrates high effectiveness regarding disease-free survival in primary lung tumors.
- Open Access
- 8 April 2026
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 28 (1) , 6-9
First experience of robotic minimally invasive esophagectomy for esophageal cancer. Retrospective study
Background. Over the past 10 to 15 years, robot-assisted esophageal resections have transitioned from an experimental technique to a significant component of surgical management for esophageal cancer. International experience has demonstrated that this approach achieves oncological outcomes comparable to those of open and conventional minimally invasive procedures, while also reducing postoperative complications. Aim. To evaluate the outcomes of surgical treatment for esophageal cancer using robot-assisted minimally invasive resections. Materials and methods. A retrospective analysis was conducted on 13 patients with intrathoracic esophageal cancer who underwent surgery between 2024 and 2025. All patients received Lewis and McKeown robot-assisted minimally invasive esophageal resections. The DaVinci Xi robotic platform was utilized during the thoracic stage in all cases. At the abdominal stage, both robotic and standard laparoscopic approaches were employed, with one patient requiring a laparotomy. Results. The mean duration of surgery was 424.2 ± 132.2 minutes (95% confidence interval: 344.2–504.1). Median intraoperative blood loss was 96.2 mL (interquartile range: 50–100). The median intensive care unit stay following surgery was 3 days (interquartile range: 1–2.5). Postoperatively, pneumonia was the most frequent complication, occurring in three patients (23%). The most severe complication was esophagogastric anastomosis dehiscence, observed in two patients (15%). In one case (7.7%), esophagogastric anastomosis dehiscence following Lewis surgery resulted in death. Conclusion. Robot-assisted resection for esophageal cancer represents an advanced and promising surgical approach that integrates oncological radicality with enhanced safety.
- 8 April 2026
- Published by Consilium Medicum in Journal of Modern Oncology
- Vol. 28 (1) , 6-9
Open AccessFirst experience of robotic minimally invasive esophagectomy for esophageal cancer. Retrospective study
Background. Over the past 10 to 15 years, robot-assisted esophageal resections have transitioned from an experimental technique to a significant component of surgical management for esophageal cancer. International experience has demonstrated that this approach achieves oncological outcomes comparable to those of open and conventional minimally invasive procedures, while also reducing postoperative complications. Aim. To evaluate the outcomes of surgical treatment for esophageal cancer using robot-assisted minimally invasive resections. Materials and methods. A retrospective analysis was conducted on 13 patients with intrathoracic esophageal cancer who underwent surgery between 2024 and 2025. All patients received Lewis and McKeown robot-assisted minimally invasive esophageal resections. The DaVinci Xi robotic platform was utilized during the thoracic stage in all cases. At the abdominal stage, both robotic and standard laparoscopic approaches were employed, with one patient requiring a laparotomy. Results. The mean duration of surgery was 424.2 ± 132.2 minutes (95% confidence interval: 344.2–504.1). Median intraoperative blood loss was 96.2 mL (interquartile range: 50–100). The median intensive care unit stay following surgery was 3 days (interquartile range: 1–2.5). Postoperatively, pneumonia was the most frequent complication, occurring in three patients (23%). The most severe complication was esophagogastric anastomosis dehiscence, observed in two patients (15%). In one case (7.7%), esophagogastric anastomosis dehiscence following Lewis surgery resulted in death. Conclusion. Robot-assisted resection for esophageal cancer represents an advanced and promising surgical approach that integrates oncological radicality with enhanced safety.
- Open Access
- 21 December 2025
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 15 (4) , 19-33
Thoracoscopic pneumonectomy in lung cancer patients: surgical technique and immediate outcomes
Background. Thoracoscopic approach was proved to be safe and effective for surgical treatment of patients with locally advanced lung cancer. However, the role of this approach in pneumonectomy has not been sufficiently studied which limits its use. Aim. To develop and implement an original safe surgical technique of thoracoscopic multiport pneumonectomy and to compare immediate surgical outcomes of open surgery and thoracoscopic (both uniport and multiport) approaches. Materials and methods. Retrospective analysis included data on patients who underwent open and thoracoscopic pneumectomy due to lung cancer between 2016 and 2023. Inclusion criteria were primary resectable lung cancer, age between 18 and 75 years, ECOG performance status 0–2. Study design involved an exploratory pilot study aimed at evaluation of immediate results of thoracoscopic pneumectomy and the rate of postoperative complications. Results. A total of 100 patients were included in study, of which 51 underwent open pneumonectomy and 49 – minimally invasive pneumonectomy, including both uniport (n = 20) and multiport (n = 29) approaches. Between the groups of thoracoscopic and open pneumectomy no differences were found in the number of dissected lymph nodes (19.1 and 22.3, respectively; p = 0.06) and the rate of R0-resections (100 and 94.1 %; p = 0.226). Median operative time was 200 min with mean values of 211.9 min in the thoracoscopy group and 210.9 min in the open surgery group (p = 0.617). Operative time did not correlate with the side of surgical intervention (p = 0.312) or the type of surgical approach (p = 0.939). Thoracoscopic pneumonectomy was associated with lower average length of hospital stay (p = 0.086) and lower duration of postoperative opioid consumption (p = 0.001) compared to open surgery. Conclusion. The obtained data show that thoracoscopic approach for pneumonectomy is equally effective as thoracotomy and decreases duration of postoperative in-hospital treatment and use of opioid analgesics. However, considering retrospective character of the study, further data validation in a prospective study is planned.
- 21 December 2025
- Published by N.N. Blokhin Cancer Fund in Surgery and Oncology
- Vol. 15 (4) , 19-33
Open AccessThoracoscopic pneumonectomy in lung cancer patients: surgical technique and immediate outcomes
Background. Thoracoscopic approach was proved to be safe and effective for surgical treatment of patients with locally advanced lung cancer. However, the role of this approach in pneumonectomy has not been sufficiently studied which limits its use. Aim. To develop and implement an original safe surgical technique of thoracoscopic multiport pneumonectomy and to compare immediate surgical outcomes of open surgery and thoracoscopic (both uniport and multiport) approaches. Materials and methods. Retrospective analysis included data on patients who underwent open and thoracoscopic pneumectomy due to lung cancer between 2016 and 2023. Inclusion criteria were primary resectable lung cancer, age between 18 and 75 years, ECOG performance status 0–2. Study design involved an exploratory pilot study aimed at evaluation of immediate results of thoracoscopic pneumectomy and the rate of postoperative complications. Results. A total of 100 patients were included in study, of which 51 underwent open pneumonectomy and 49 – minimally invasive pneumonectomy, including both uniport (n = 20) and multiport (n = 29) approaches. Between the groups of thoracoscopic and open pneumectomy no differences were found in the number of dissected lymph nodes (19.1 and 22.3, respectively; p = 0.06) and the rate of R0-resections (100 and 94.1 %; p = 0.226). Median operative time was 200 min with mean values of 211.9 min in the thoracoscopy group and 210.9 min in the open surgery group (p = 0.617). Operative time did not correlate with the side of surgical intervention (p = 0.312) or the type of surgical approach (p = 0.939). Thoracoscopic pneumonectomy was associated with lower average length of hospital stay (p = 0.086) and lower duration of postoperative opioid consumption (p = 0.001) compared to open surgery. Conclusion. The obtained data show that thoracoscopic approach for pneumonectomy is equally effective as thoracotomy and decreases duration of postoperative in-hospital treatment and use of opioid analgesics. However, considering retrospective character of the study, further data validation in a prospective study is planned.